-+ 0.00%
-+ 0.00%
-+ 0.00%

VistaGen appoints Angel Angelov as chief medical officer

PUBT·05/19/2026 12:30:45
Listen to the news
VistaGen appoints Angel Angelov as chief medical officer
  • VistaGen Therapeutics appointed Angel S. Angelov as chief medical officer, effective May 18, 2026.
  • Angelov most recently served as chief medical officer at Theranica, a neuromodulation therapeutics company.
  • He previously held senior clinical development or medical affairs roles at Karuna Therapeutics, Neurocrine Biosciences, Novartis, and Teva.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. VistaGen Therapeutics Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260519798012) on May 19, 2026, and is solely responsible for the information contained therein.